ロード中...
The rationale for targeted therapies in medulloblastoma
Medulloblastoma (MB) is the most frequent malignant brain tumor in children. Patients with MB who are classified as having high-risk disease or those with recurrent disease respond poorly to current therapies and have an increased risk of MB-related mortality. Preclinical studies and molecular profi...
保存先:
| 主要な著者: | , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Oxford University Press
2014
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3870836/ https://ncbi.nlm.nih.gov/pubmed/24305711 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/not147 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|